9
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Oral Administration of Type I Interferon Modulates the Course of Experimental Allergic Neuritis

, , , &
Pages 157-165 | Received 19 Apr 1996, Accepted 10 Jul 1996, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hong-Liang Zhang, Limin Wu, Xiujuan Wu & Jie Zhu. (2014) Can IFN-γ be a therapeutic target in Guillain-Barré syndrome?. Expert Opinion on Therapeutic Targets 18:4, pages 355-363.
Read now

Articles from other publishers (20)

Felix Kohle, Marinos C. Dalakas & Helmar C. Lehmann. (2023) Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?. Therapeutic Advances in Neurological Disorders 16, pages 175628642211371.
Crossref
Sonoko Misawa & Tomoki Suichi. (2020) Guillain‐Barré syndrome: Novel treatment by complement inhibition. Clinical and Experimental Neuroimmunology 11:2, pages 90-93.
Crossref
Michael P.T. Lunn, Helmar C. Lehmann & Kazim A. Sheikh. 2020. The Autoimmune Diseases. The Autoimmune Diseases 987 1009 .
Duncheng Wang, Debjani Ghosh, S. M. Touhidul Islam, Cody D. Moorman, Ashton E. Thomason, Daniel S. Wilkinson & Mark D. Mannie. (2016) IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis. The Journal of Immunology 197:8, pages 2992-3007.
Crossref
Michael P.T. Lunn & Kazim A. Sheikh. 2014. The Autoimmune Diseases. The Autoimmune Diseases 757 776 .
Joerg-Patrick Stübgen. (2009) Recombinant interferon-beta therapy and neuromuscular disorders. Journal of Neuroimmunology 212:1-2, pages 132-141.
Crossref
Mark D. Mannie, Derek J. Abbott & J. Lori Blanchfield. (2009) Experimental Autoimmune Encephalomyelitis in Lewis rats: IFN-β Acts As a Tolerogenic Adjuvant for Induction of Neuroantigen-Dependent Tolerance. The Journal of Immunology 182:9, pages 5331-5341.
Crossref
G. Dati, A. Quattrini, L. Bernasconi, M.C. Malaguti, B. Antonsson, F. Nicoletti, C. Alliod, R. Di Marco, Y. Sagot, P.A. Vitte, A. Hiver, B. Greco, A. Roach & P.F. Zaratin. (2007) Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies. Journal of Neuroimmunology 190:1-2, pages 8-17.
Crossref
Jude Matthew Taylor & John David Pollard. (2007) Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood–nerve-barrier permeability and inflammation. Journal of Neuroimmunology 183:1-2, pages 118-124.
Crossref
MICHAEL P.T. LUNN & KAZIM A. SHEIKH. 2006. The Autoimmune Diseases. The Autoimmune Diseases 633 651 .
Joseph M. Cummins, G. Steven Krakowka & Chad G. Thompson. (2005) Systemic effects of interferons after oral administration in animals and humans. American Journal of Veterinary Research 66:1, pages 164-176.
Crossref
C Polman, F Barkhof, L Kappos, C Pozzilli, R Sandbrink, F Dahlke, P Jakobs & A Lorenz. (2016) Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study. Multiple Sclerosis Journal 9:4, pages 342-348.
Crossref
Staley A. Brod. (2002) Ingested Type I Interferon: A Potential Treatment for Autoimmunity. Journal of Interferon & Cytokine Research 22:12, pages 1153-1166.
Crossref
Alain Cr??ange. (2000) A Role for Interferon-?? in Guillain-Barr?? Syndrome?. BioDrugs 14:1, pages 1-11.
Crossref
Staley A. Brod, Stephen Katz, Tammy Phan & Stanislaw Stepkowski. (2000) INGESTED INTERFERON-?? PREVENTS ALLOGRAFT ISLET TRANSPLANT REJECTION1. Transplantation 69:10, pages 2162-2166.
Crossref
Roberto Di Marco, Mohsen Khademi, Erik Wallstrom, Saad Muhallab, Ferdinando Nicoletti & Tomas Olsson. (1999) Amelioration of Experimental Allergic Neuritis by Sodium Fusidate (Fusidin): Suppression of IFN-γ and TNF-α and Enhancement of IL-10. Journal of Autoimmunity 13:2, pages 187-195.
Crossref
Staley A. Brod. (1999) Autoimmunity Is a Type I Interferon-Deficiency Syndrome Corrected by Ingested Type I IFN via the GALT System. Journal of Interferon & Cytokine Research 19:8, pages 841-852.
Crossref
Alain Créange, Hervé Lerat, Christian Meyrignac, Jean-Denis Degos, Romain K Gherardi & Pierre Cesaro. (1998) Treatment of Guillain-Barré syndrome with interferon-β. The Lancet 352:9125, pages 368-369.
Crossref
Jie Zhu, Eilhard Mix & Hans Link. (1998) Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain–Barré syndrome. Journal of Neuroimmunology 84:1, pages 40-52.
Crossref
Kenneth C. Gorson, Gregory Allam, Drasko Simovic & Allan H. Ropper. (1997) Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy. Neurology 48:3, pages 777-780.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.